Ebola infection in Dallas nurse underscores critical need for proper training
A nurse in Dallas who was treating the first case of Ebola diagnosed in the United States has become infected with the virus herself even though she was wearing protective gear. The case has similarities to that of a nurse infected in a Spanish hospital after taking care of a priest who had contracted the disease in Sierra Leone, and both raise questions about the training procedures that hospital staff receive before they come into contact with Ebola patients.
See all of Science's coverage of the Ebola outbreak, including the development of drugs and vaccines, 11 things we'd like to know about the new Ebola case, and what the virus actually does.
Recent volcanic eruptions on the moon
The moon, thought to be cold and dead, is still alive and kicking—barely. Scientists have found evidence for dozens of burps of volcanic activity, all within the past 100 million years—a mere blip on the geologic timescale. And they think that future lunar eruptions are likely—although probably not within a human lifetime.
Smart battery tells you when it's about to explode
Compact and rechargeable lithium-ion batteries are everywhere—they're in our laptops, phones, and cars. But they have a significant drawback: Occasionally, the batteries burst into flames. Now, material scientists have found a clever way to alert users of damaged batteries before any hazard occurs.
Uprising: Less prestigious journals publishing greater share of high-impact papers
The world of academic publishing is an oligarchy. Not only are the vast majority of highly cited papers authored by an elite 1% of scientists, but a small group of elite journals also get the lion's share of citations and media attention. But this rarified world is becoming more egalitarian, according to a new study that provides the strongest evidence yet that the dominance of the elite journals is eroding, thanks in part to how much easier it has become for scientists to find and cite obscure but relevant papers.
Stem cell therapy seems safe for severe eye disease
The first people to receive stem cell treatment for eye disease are showing no complications after nearly 2 years. The outcome may pave the way for transplants of stem cell–derived eye cells, which could dramatically improve vision in people with eye disease.









